NCT03392350 Randomized Trial of the Impact of Body Scanning and Intensive Behavioral Intervention on Behavioral Change and Health Outcomes Status COMPLETED Phase NA
NCT03381287 A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia Status COMPLETED Phase PHASE1/PHASE2
NCT03379558 Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study Status TERMINATED Phase N/A
NCT03366688 Single Ascending Dose Study of PCSK-9 Inhibitor (IBI306) in Healthy Subjects. Status COMPLETED Phase PHASE1
NCT03346733 The Effect of Psyllium Fibre on LDL-C, Non-HDL-C, and Apolioprotein-B: A Systematic Review and Meta-analysis Status UNKNOWN Phase N/A
NCT03288038 The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT03284918 Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester Status COMPLETED Phase NA
NCT03206164 HealthMatters@24/7 eLearning for People Supporting Adults With Intellectual and Developmental Disabilities Status COMPLETED Phase NA
NCT03193047 Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy Status COMPLETED Phase PHASE2
NCT03175367 Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT03172611 A Defined, Plant-based, 4-week Dietary Intervention Reduces Lp(a) and Other Atherogenic Particles Status COMPLETED Phase NA
NCT03161327 Digital Ankle Brachial Index (ABI) as a Screening Tool in Detecting Peripheral Arterial Disease Status COMPLETED Phase NA
NCT03074630 Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2) Status COMPLETED Phase PHASE4
NCT03067441 Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE) Status COMPLETED Phase PHASE3
NCT03065491 Effect of Red Yeast Rice, Phytosterols and L-tyrosol on Lipid Profile and Endothelial Function Status COMPLETED Phase NA
NCT03051100 Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C Status COMPLETED Phase PHASE2